Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.71 |
| ▸ | MEN1 | O00255 | 4/20 | 0.71 |
| ▸ | NPC1 | O15118 | 2/20 | 0.71 |
| ▸ | RAB9A | P51151 | 1/20 | 0.71 |
| ▸ | POLB | P06746 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1751022 | 0.91 | KMT2A (0.69) | KMT2AMEN1NPC1RAB9APOLB | |
| SCHEMBL1801128 | 0.82 | NPC1 (0.80) | KMT2AMEN1NPC1RAB9APOLB | |
| SCHEMBL13982684 | 0.79 | KDM4E (0.56) | KMT2AMEN1NPC1RAB9AALDH1A1 | |
| SCHEMBL6396043 | 0.79 | KMT2A (0.71) | KMT2AMEN1NPC1RAB9APOLB | |
| SCHEMBL6392561 | 0.78 | NPC1 (0.70) | KMT2AMEN1NPC1RAB9APOLB | |
| SCHEMBL11742509 | 0.77 | HTR2A (0.61) | KMT2AMEN1POLBALDH1A1CYP3A4 | |
| SCHEMBL16109698 | 0.77 | HSD17B10 (0.61) | POLBALDH1A1CYP3A4TDP1HPGD | |
| SCHEMBL12218241 | 0.76 | POLB (1.00) | KMT2AMEN1NPC1RAB9APOLB | |
| SCHEMBL28465013 | 0.76 | NPC1 (0.81) | KMT2AMEN1NPC1RAB9APOLB | |
| SCHEMBL2925120 | 0.73 | TRPV1 (0.70) | KMT2AMEN1NPC1RAB9APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7968735-B2 | Light-emitting biomarker | QUIDD (FR) | 2011-06-28 | — | — | US | disclosed |
| US-7968735-B2 | Light-emitting biomarker | QUIDD (FR) | 2011-06-28 | — | — | US | disclosed |
| US-7968735-B2 | Light-emitting biomarker | QUIDD (FR) | 2011-06-28 | — | — | US | disclosed |
| US-20090041669-A1 | Light-Emitting Biomarker | QUIDD (FR) | 2009-02-12 | — | — | US | disclosed |
| US-20090041669-A1 | Light-Emitting Biomarker | QUIDD (FR) | 2009-02-12 | — | — | US | disclosed |
| US-20090041669-A1 | Light-Emitting Biomarker | QUIDD (FR) | 2009-02-12 | — | — | US | disclosed |
| EP-1883635-A2 | LIGHT-EMITTING BIOMARKER | Quidd (FR) | 2008-02-06 | — | — | EP | disclosed |
| WO-2006129036-A2 | LIGHT-EMITTING BIOMARKER | QUIDD (FR) | 2006-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090041669-A1 | Light-Emitting Biomarker | ALDH1A2, CYP19A1, GUSB | KMT2A 3231/4885MEN1 2465/4885NPC1 3751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.